Will MICA glitter for recipients of kidney transplants?

New England Journal of Medicine

Volumn 357, Issue 13, 2007, Pages 1337-1339

  Flegel, Willy Albert ^a  

^a German Red Cross Blood Transfusion Service Baden Württemberg Hessen and University Hospital Ulm   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD GROUP A ANTIGEN; BLOOD GROUP B ANTIGEN; BLOOD GROUP O ANTIGEN; HLA A ANTIGEN; HLA B ANTIGEN; HLA DR ANTIGEN; IMMUNOSUPPRESSIVE AGENT; MAJOR HISTOCOMPATIBILITY ANTIGEN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; MAJOR HISTOCOMPATIBILITY COMPLEX CLASS 1 RELATED CHAIN A ANTIGEN; NATURAL KILLER CELL RECEPTOR NKG2D; UNCLASSIFIED DRUG;

ANTIGEN BINDING; ANTIGEN EXPRESSION; CD8+ T LYMPHOCYTE; CHROMOSOME 6; EDITORIAL; GENE LOCUS; GRAFT SURVIVAL; HLA MATCHING; HUMAN; IMMUNE SYSTEM; IMMUNOGENETICS; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY FAILURE; KIDNEY GRAFT REJECTION; KIDNEY TRANSPLANTATION; MAJOR HISTOCOMPATIBILITY COMPLEX; ORGAN TRANSPLANTATION; PRIORITY JOURNAL; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 34748858477     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJMe078165     Document Type: Editorial

References (16)

1. Opelz G, Döhler B. Effect of human leukocyte antigen compatibility on kidney graft survival: comparative analysis of two decades. Transplantation 2007;84:137-43.
2. Opelz G, Wujciak T, Döhler B, Scherer S, Mytilineos J. HLA compatibility and organ transplant survival: Collaborative Transplant Study. Rev Immunogenet 1999;1:334-42.
3. Nydegger UE, Riedler GF, Flegel WA. Histoblood groups other than HLA in organ transplantation. Transplant Proc 2007;39:64-8.
4. Lerut E, Van Damme B, Noizat-Pirenne F, et al. Duffy and Kidd blood group antigens: minor histocompatibility antigens involved in renal allograft rejection? Transfusion 2007;47:28-40.
5. Bahram S, Bresnahan M, Geraghty DE, Spies T. A second lineage of mammalian major histocompatibility complex class I genes. Proc Natl Acad Sci U S A 1994;91:6259-63.
6. Zwirner NW, Marcos CY, Mirbaha F, Zou Y, Stastny P. Identification of MICA as a new polymorphic alloantigen recognized by antibodies in sera of organ transplant recipients. Hum Immunol 2000;61:917-24.
7. Mizutani K, Terasaki P, Bignon JD, et al. Association of kidney transplant failure and antibodies against MICA. Hum Immunol 2006;67:683-91.
8. Zou Y, Stastny P, Süsal C, Döhler B, Opelz G. Antibodies against MICA antigens and kidney-transplant rejection. N Engl J Med 2007;357:1293-300.
9. Gao X, Single RM, Karacki P, Marti D, O'Brien SJ, Carrington M. Diversity of MICA and linkage disequilibrium with HLA-B in two North American populations. Hum Immunol 2006;67:152-8.
10. Buetens O, Shirey RS, Goble-Lee M, et al. Prevalence of HLA antibodies in transfused patients with and without red cell antibodies. Transfusion 2006;46:754-6.
11. Holdenrieder S, Stieber P, Peterfi A, Nagel D, Steinle A, Salih HR. Soluble MICA in malignant disease. Int J Cancer 2006;118:684-7.
12. Rebmann V, Schütt P, Brandhorst D, et al. Soluble MICA as an independent prognostic factor for the overall survival and progression-free survival of multiple myeloma patients. Clin Immunol 2007;123:114-20.
13. Flegel WA. Homing in on D antigen immunogenicity. Transfusion 2005;45:466-8.
14. Hirv K, Pannicke U, Mytilineos J, Schwarz K. Disulfide bridge disruption in the alpha 2 domain of the HLA class I molecule leads to low expression of the corresponding antigen. Hum Immunol 2006;67:589-96.
15. Ruggeri L, Mancusi A, Burchielli E, Aversa F, Martelli MF, Velardi A. Natural killer cell alloreactivity in allogeneic hematopoietic transplantation. Curr Opin Oncol 2007;19:142-7.
16. Terasaki PI, Ozawa M, Castro R. Four-year follow-up of a prospective trial of HLA and MICA antibodies on kidney graft survival. Am J Transplant 2007;7:408-15.